A new era in the treatment of fibroids

The company Richter Gedeon presented the first pharmacological treatment option for the treatment of uterine myomas ulipristal acetate (UPA) to the local professional community.
The advantages of this innovative treatment of fibroids unique drug on the market, proven effectiveness in many countries around the world and the security of the application, at a meeting held yesterday at the Crowne Plaza, spoke of Prof Dr. Ana Mitrovic Jovanovic, Jasmina Atanackovic and Marija Milic Asist. Dr PhD Faculty of Pharmacy, University of Belgrade. This original, the most modern medicament for the illness which is faced by 40% of the female population in the world, now is available for our women.